deltatrials
Unknown PHASE1 NCT00006127

Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia

Sponsor: Dana-Farber Cancer Institute

Conditions Fanconi's Anemia
Interventions amifostine
Updated 5 times since 2017 Last updated: Jun 23, 2005 Started: Apr 30, 2000

A PHASE1 clinical study on Fanconi's Anemia, this trial is ongoing. The trial is conducted by Dana-Farber Cancer Institute and has accumulated 5 data snapshots since 2000. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE1

    First recorded

Apr 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dana-Farber Cancer Institute
Data source: Office of Rare Diseases (ORD)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Boston, United States